Prospective evaluation of oral mucositis in acute leukemia patients receiving chemotherapy

Supportive Care in Cancer

Volumn 18, Issue 5, 2010, Pages 639-646

  Ramírez Amador, Velia ^a   Anaya Saavedra, Gabriela ^a   Crespo Solís, Erick ^b   Camacho, Esther Irigoyen ^a   González Ramírez, Imelda ^a   Ponce de León, Sergio ^b  

^a DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Acute leukemia; Chemotherapy; Oral mucositis; Salivary flow

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE HYBRID LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BEHAVIOR; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; COHORT ANALYSIS; CONTINUOUS INFUSION; DYSPHAGIA; FEMALE; FLOW MEASUREMENT; FOOD INTAKE; HUMAN; LONGITUDINAL STUDY; MALE; MOUTH DISEASE; MOUTH PAIN; MUCOSA INFLAMMATION; ORAL MUCOSITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; RISK FACTOR; SALIVA ANALYSIS; SCORING SYSTEM; TREATMENT DURATION; VISUAL ANALOG SCALE;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LEUKEMIA; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STOMATITIS; YOUNG ADULT;

EID: 77953620269     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-009-0708-1     Document Type: Article

References (49)

1. Scully C, Sonis S, Diz PD (2006) Oral mucositis. Oral Dis12:229-241
2. Woo SB, Sonis ST, Monopoli MM, Sonis AL (1993) Alongitud in al study of oral ulcerative mucositis in bone marrowtransplant recipients. Cancer 72:1612-1617
3. Wardley AM, Jayson GC, Swindell R et al (2000) Prospectiveevaluationof oral mucositis in patients receiv ing myeloablativecondition ing regimens and haemato poietic progenito r rescue. Br J Haemato l 110:292-299
4. Sonis ST (2007) Pathobiology of oral mucositis: Novelin sightsand opportunities. J Support Oncol 5:3-11
5. Logan RM, Gibson RJ, Sonis ST, Keefe DM (2007) Nuclearfacto r-kappaB (NF-kappaB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa follow ing cancer chemotherapy.Oral Oncol 43:395-401
6. Köstler WJ, Hejna M, Wenzel C, Zielinski CC (2001) Oralmucositis complicat ing chemotherapy and/or radiotherapy: Optionsfor prevention and treatment. CA Cancer J Clin 51:290-315
7. Blijlevens N, SchwenkglenKs M, Bacon P et al (2008) Europeanblood and marrow transplantation mucositis advisory group.Prospective oral mucositis audit: Oral mucositis in patientsreceiv ing high-dose melphalanor BEAM condition ing chemotherapy-European Blood and Marrow Transplantation MucositisAdvisory Group. J Clinoncol 26:1519-1525
8. Vera-Llonch M, Oster G, Ford CM, Lu J, Sonis S (2007) Oralmucositis and outcomes of auto logous hemato poietic stem-celltransplantation follow ing high-dose melphalan condition ing formultiple myeloma. J Support Oncol 5:231-235
9. Avritscher EB, Cooksley CD, Elting LS (2004) Scope andepidemiology of cancer therapy- in duced oral and gastro in test in almucositis. Sem inoncol Nurs 20:3-10
10. Bolwell BJ, Kalaycio M, Sobecks R et al (2002) A multivariableanalysis of facto rs in fluenc ing mucositis after auto logous progenito rcell transplantation. Bone Marrow Transplant 30:587-591
11. Cheng KK, Goggins WB, Lee VW, Thompson DR (2008) Risk facto rs for oral mucositis in children undergo ing chemotherapy: Amatched case-control study. Oral Oncol 44:1019-1025
12. Vokurka S, Bystrická E, Koza V et al (2006) Higher in cidence of chemotherapy in duced oral mucositis in females: A Suppl ement of multivariate analysis to a randomized multicentre study. Support Care Cancer 14:974-976
13. Barasch A, Peterson DE (2003) Risk facto rs for ulcerative oralmucositis in cancer patients: Unanswered questions. Oral Oncol39:91-100
14. Repetto L (2003) Greater risks of chemotherapy to xicity in elderlypatients with cancer. J Support Oncol 1:18-24
15. McCarthy GM, Awde JD, Ghandi H, Vincent M, Kocha WI (1998) Risk facto rs associated with mucositis in cancer patientsreceiv ing 5-fluorouracil. Oral Oncol 34:484-490
16. Robienk, Schubert MM, Bruemmer B, Lloid ME, Potter JD,Ulrich CM (2004) Predicto rs of oral mucositis in patientsreceiv ing hemato poietic cell transplants for chronic myelogenousleukemia. J Clinoncol 22:1268-1275
17. vankuilenburg AB, Haasjes J, Richel DJ et al (2000) Clin icalimplications of dihydropyrimid ine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated to xicity: Identificationof new mutations in the DPD gene. Clin Cancer Res 6:4705-4712
18. Mutchinick OM, López MA, Luna L, Waxman J, Babinsky VE (1999) High prevalence of the thermolabile methylenetetrahydr of olatereductase variant in Mexico: A country with a very highprevalence of neural tube defects. Mol Genet Metab 68:461-467
19. Wahlin YB, Matsson L (1988) Oral mucosal lesions in patientswith acute leukemia and related disorders dur ing cyto to xictherapy. Scand J Dent Res 96:128-136
20. Dreizen S, McCredie KB, Bodey GP, Keating MJ (1986) Quantitative analysis of the oral complications of antileukemiachemotherapy. Oral Surg Oral Med Oral Pathol 62:650-653
21. Barrett AP (1987) Clin ical characteristics and mechanisms in volved in chemotherapy- in duced oral ulceration. Oral Surg Oral Med Oral Pathol 63:424-428
22. STROBE Group. STROBE Statement. Checklist of essentialitems, version 3. http://www.strobe.statement.org/PDF/STROBEChecklist-Version3.pdf. Accessed January 30, 2009.
23. Omura GA, Vogler WR, Lefante J et al (1982) Treatment of acutemyelogenous leukemia: In fluence of three in duction regimens andma in tenance with chemotherapy of BCG immunotherapy. Cancer49:1530-1536
24. Arteaga-Ortiz L, Buitrón-Santiago N, Rosas-López A et al (2008) Acutelimphoblastic leukemia: Experience in adults patientstreated with hyperCVAD and 0195 Proto col, at the in stituteNacional de Ciencias Ḿdicas y Nutrición Salvador Zubirán.Cohort 2003-2007. Rev in vest Clin 60 (6):459-469
25. Sonis ST, Eilers JP, Epstein JB et al (1999) Validationof a newscor ing system for the assessment of clin ical trial research of oralmucositis in duced by radiationor chemotherapy. Mucositis StudyGroup. Cancer 85:2103-2113
26. López-Jornet P, Camacho-Alonso F, Bermejo-Fenoll A (2006) Asimple test for salivary gland hyp of unction us ing Oral Schirmer'stest. J Oral Pathol Med 35:244-248
27. Greene JC, Vermillion JR (1964) the simplified oral hygiene in dex. J Am Dent Assoc 68:7-13
28. Matthews JN, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ300:230-235 (Pubitemid 20045528)
29. Matthews DE, Farewell VT (1985) Us ing and understanDing medical statistics. Karger, Basel
30. Figliolia SL, Oliveira DT, Pereira MC et al (2008) Oral mucositis in acute lymphoblastic leukaemia: Analysis of 169 paediatricpatients. Oral Dis 14:761-766
31. Maiguma T,HayashiY, Ueshima S et al (2008) Relationship betweenoral mucositis and high-dose methotrexate therapy in pediatric acutelymphoblastic leukemia. in t J Clin Pharmacol ther 46:584-590
32. Raber-Durlacher JE, Weijl NI, Abu Saris M, de Kon ing B,Zwinderman AH, Osanto S (2000) Oral mucositis in patientstreated with chemotherapy for solid tumors: A retrospectiveanalysis of 150 cases. Support Care Cancer 8:366-371
33. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E,Rubenstein EB (2003) the burdens of cancer therapy. Clin ical andeconomic outcomes of chemotherapy- in duced mucositis. Cancer98:1531-1539
34. Chan CW, Chang AM, Molassiotis A, Lee IY, Lee GC (2003) Oral complications in Ch in ese cancer patients undergo ing chemotherapy.Support Care Cancer 11:48-55
35. Fall-Dickson JM, Ramsay ES, Castro K, Woltz P, Sport́s C (2007) Oral mucositis-related oropharyngeal pa in and correlativetumor necrosis facto r-alpha expression in adult oncology patientsundergo ing hemato poietic stem cell transplantation. Clin ther29:2547-2561
36. Elad S, Ackerstein A, Bitan M et al (2006) A prospective, doubleblin dphase II study evaluat ing the safety and efficacy of a to picalhistam ine gel for the prophylaxis of oral mucositis in patients posthe mato poietic stem cell transplantation. Bone Marrow Transplant37:757-762
37. Shovali, Kushner JA, Sukhu B et al (2005) therelationshipbetween mouthr in se matrix metalloprote in ases (MMP-1, 8, 13) and album in levels with the degree of oral mucositis in allogeneicstem cell transplant patients. Bone Marrow Transplant 36:33-38
38. Epstein JB, Schubert MM (1999) Oral mucositis in myelosup-pressive cancer therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88:273-276
39. Sung L, Tomlinson GA, Greenberg ML et al (2007) Validationof the oral mucositis assessment scale in pediatric cancer. Pediatr Blood Cancer 49:149-153
40. Sonis ST, Oster G, Fuchs H et al (2001) Oral mucositis and the clin ical and economic outcomes of hemato poietic stem-celltransplantation. J Clinoncol 19:2201-2205
41. Cella D, Pulliam J, Fuchs H et al (2003) Evaluationof pa in associated with oral mucositis dur ing the acute period afteradm in istrationof high-dose chemotherapy. Cancer 98:406-412
42. Lara-Muñoz C, De Leon SP, Feinstein AR, Puente A, Wells CK (2004) Comparisonof three rat ing scales for measur ing subjectivephenomena in clin ical research. I. Use of experimentally controlledaudito ry stimuli. Arch Med Res 35:43-48
43. Vissink A, Burlage FR, Spijkervet FK, Veerman EC, NieuwAmerongen AV (2004) Prevention and treatment of salivary glandhyp of unction related to head and neck radiation therapy andchemotherapy. Support Cancer ther 1:111-118
44. Blomgren J, Jansson S, Rödjer S, Birkhed D (2002) Secretion ratefrom m inor salivary glands in patients with malignant haemato logicaldiseases receiv ing chemotherapy-a pilot study. SwedDent J 26:75-80
45. Epstein JB, Tsang AH, Warkentin D, Ship JA (2002) therole of salivary function in modulat ing chemotherapy- in duced oropha-ryngeal mucositis: A review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94:39-44
46. OhrnkE, Wahlin YB, Sjöd́n PO (2001) Oral status dur in gradiotherapy and chemotherapy: A descriptive study of patientexperiences and the occurrence of oral complications. Support Care Cancer 9:247-257
47. Keefe DM, Schubert MM, Elting LS et al (2007) Mucositis studysectionof the mult in ational associationof supportive care in cancer and the in ternational society for oral oncology. Updatedclin ical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820-831
48. Epstein JB, Silverman S Jr, PaggiarinoDAet al (2001) Benzydam in eHCl for prophylaxis of radiation- in duced oral mucositis: Results froma multicenter, randomized, double-blin d, placebo-controlled clin icaltrial. Cancer 92:875-885
49. Kazemian A, Kamian S, Aghili M, Hashemi FA, Haddad P (2009) Benzydam ine for prophylaxis of radiation- in duced oralmucositis in head and neck cancers: A double-blin d placebocontrolledrandomized clin ical trial. Eur J Cancer Care (Engl) 18:174-178